Posted by Michael Wonder on 18 Mar 2022
Advocates say PHARMAC too slow on drugs to help treat COVID-19
19 March 2022 - Kiwis have been left waiting for a new antiviral drug to treat COVID-19 because PHARMAC was too slow to sign a supply contract with the manufacturer, a patient advocacy group says.
But PHARMAC says despite Medsafe giving Pfizer's Paxlovid the green light this month, it is the sheer demand for the medicine globally which is holding up delivery.
